Biomaterials For Modern Cancer Imaging And Therapies: Methylene Blue For Fluorescence And Photoacoustic Imaging And Light-induced Cancer Therapy | Agenda Bookshop Skip to content
Online orders placed from 19/12 onward will not arrive in time for Christmas.
Online orders placed from 19/12 onward will not arrive in time for Christmas.
A01=Maoquan Chu
Age Group_Uncategorized
Age Group_Uncategorized
Author_Maoquan Chu
automatic-update
Category1=Non-Fiction
Category=MMPH
Category=MQW
COP=Singapore
Delivery_Delivery within 10-20 working days
Language_English
PA=Available
Price_€50 to €100
PS=Active
softlaunch

Biomaterials For Modern Cancer Imaging And Therapies: Methylene Blue For Fluorescence And Photoacoustic Imaging And Light-induced Cancer Therapy

English

By (author): Maoquan Chu

Methylene blue (MB) is a biocompatible and environmentally friendly material that has been widely used in clinical and biomedical research fields for over a century. In addition, it also has wide applications in other fields, such as dyeing and finishing industry, aquaculture industry, photocatalysis and food industry.This landmark publication is unique as it covers MB-mediated in vivo fluorescence, photoacoustic imaging and light-induced cancer therapy. The optical properties and photothermal effect of MB are also systematically described. See more
Current price €89.29
Original price €93.99
Save 5%
A01=Maoquan ChuAge Group_UncategorizedAuthor_Maoquan Chuautomatic-updateCategory1=Non-FictionCategory=MMPHCategory=MQWCOP=SingaporeDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=AvailablePrice_€50 to €100PS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Publication Date: 06 May 2024
  • Publisher: World Scientific Publishing Co Pte Ltd
  • Publication City/Country: Singapore
  • Language: English
  • ISBN13: 9789811277696

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept